Akero Therapeutics (AKRO) Q1 2025 Earnings

Feb 28Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.16
-1.04
-0.93
-0.81

Details

Expected EPS
-1.161275
Actual EPS
-0.99
Surprise EPS
0.17
Surprise Percent
+14.75%

Description

⁨Akero Therapeutics⁩ (⁦AKRO⁩) has reported earnings of ⁦-0.99⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts